Taylor Wirth, accomplice at Barnes & Thornburg Life sciences firms, particularly people who make investments closely in analysis and growth, are sometimes confronted with crucial financing choices. Ought to they pursue an preliminary public providing (IPO) to gas their progress, or is a strategic buyout of a bigger firm a extra applicable path? On this unique interview, Taylor Wirth, accomplice […]